Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 206-076-3 | CAS number: 299-29-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Ferrous gluconate is devoid of mutagenic properties and is thus classified as non-hazardous for this end point There are no studies for this endpoint on ferrous gluconate. Results of studies conducted with a structurally similar compound, Glucono-delta-lactone, are reported and used for read across. From this read across ferrous gluconate is classsified as non-hazardous for this endpoint. Read across justification summary is attached to the end point summary
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1974
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- Missing S. typhimurium strains TA98, TA100, and TA102 or E. coli strain WP2 uvrA; use of only 1 (in plate) and 2 (in suspension) concentrations instead of recommended 5.
- GLP compliance:
- no
- Remarks:
- Study predates GLP
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535
- Additional strain / cell type characteristics:
- not applicable
- Species / strain / cell type:
- S. typhimurium TA 1537
- Additional strain / cell type characteristics:
- not applicable
- Species / strain / cell type:
- S. typhimurium TA 1538
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- Lung, liver, and testes homogenates from adult male mice, rats, and monkeys
- Test concentrations with justification for top dose:
- 0.50% (plate method) and 0.25% or 0.50% (suspension method)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Saline or <10% DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 2-acetylaminofluorene
- 2-nitrofluorene
- N-dimethylnitrosamine
- ethylmethanesulphonate
- other: Quinacrine Mustard
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- other: For plate tests, it is not clear if the vehicle controls were valid since no numerical results were reported. For suspension tests, vehicle controls appear to be valid.
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- other: For plate tests, it is not clear if the positive controls were valid since no numerical results were reported. For suspension tests, some of the positive control results do not appear to be valid.
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- other: For plate tests, it is not clear if the vehicle controls were valid since no numerical results were reported. For suspension tests, vehicle controls appear to be valid.
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- other: For plate tests, it is not clear if the positive controls were valid since no numerical results were reported. For suspension tests, some of the positive control results do not appear to be valid.
- Species / strain:
- S. typhimurium TA 1538
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- other: For plate tests, it is not clear if the vehicle controls were valid since no numerical results were reported. For suspension tests, vehicle controls appear to be valid.
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- other: For plate tests, it is not clear if the positive controls were valid since no numerical results were reported. For suspension tests, some of the positive control results do not appear to be valid.
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
negative with metabolic activation
negative without metabolic activation
Glucono-delta-lactone, was negative both with or without metabolic activaton. However, some of the positive controls did not appear to be valid. - Executive summary:
Compound FDA 71 -72, glucono-delta-lactone, was negative both with or without metabolic activaton. However, some of the positive controls did not appear to be valid.
- Endpoint:
- genetic toxicity in vitro
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1974
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 480 (Genetic Toxicology: Saccharomyces cerevisiae, Gene Mutation Assay)
- Deviations:
- yes
- Remarks:
- only 2 concentrations used; post-treatment incubation was 3-5 days; study done only once; positive control in the presence of S9 did not produce anticipated results so results deemed unreliable
- GLP compliance:
- no
- Remarks:
- Study predates GLP
- Type of assay:
- gene mutation assay in fungi
- Species / strain / cell type:
- Saccharomyces cerevisiae
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- Lung, liver, and testes homogenates from adult male mice, rats, and monkeys (it was not reported whether or not an enzyme inducer was used)
- Test concentrations with justification for top dose:
- Concentrations reported as "high-dose" and "low-dose"
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- saline
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- N-dimethylnitrosamine
- ethylmethanesulphonate
- Species / strain:
- Saccharomyces cerevisiae
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- not valid
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
negative with metabolic activation
negative without metabolic activation
Glucono-delta-lacton, was not genetically active, either directly or in the presence of organ homogenates, in any of the in vitro assays employed in this evaluation - Executive summary:
Compound FDA 71 -72, glucono-delta-lacton, was not genetically active, either directly or in the presence of organ homogenates, in any of the in vitro assays employed in this evaluation
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
Link to relevant study records
- Endpoint:
- in vivo mammalian germ cell study: gene mutation
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- documentation insufficient for assessment
- GLP compliance:
- not specified
- Type of assay:
- Drosophila SLRL assay
- Species:
- Drosophila melanogaster
- Strain:
- not specified
- Sex:
- male
- Route of administration:
- oral: unspecified
- Duration of treatment / exposure:
- 10 days
- Key result
- Sex:
- male
- Genotoxicity:
- negative
- Conclusions:
- Interpretation of results (migrated information): negative
ferrous gluconate is devoid of mutagenic properties. - Executive summary:
This substantial paper is principally an introduction to the method. The Drosophila test is considered to check for mutations at 600 to 800 loci. It can detect both point mutagens and promutagens which require activation. Ferrous gluconate was one of 421 substances tested. The objective being to correlate known carcinogenic properties with this mutagenic end-point. The authors of the study, reviewed in this US-EPA report, found ferrous gluconate to be devoid of mutagenic properties.
Reference
Ferrous Gluconate was not mutagenic at any exposure level used. Ferrous Gluconate was devoid of mutagenic properties.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Justification for classification or non-classification
Results from in vivo studies confirmed that Iron Gluconate is classified as non-hazardous for this end point.
Results of an in vitro study conducted with a structurally similar compoud, Glucono delta-lactone, are reported and used for read across. Iron Gluconate did not contain any structural alerts for mutagenicity. The lack of alert and the physical-chemical properties indicate that iron gluconate should not be reactive to DNA.
Iron Gluconate consists of two gluconanic acids coordinated in an ionic bond with the ferrous ion. The molecule readily dissociates to form free gluconic acid which then cyclizes to form the corresponding lactone. D-glucono-1,5-lactone is the stable intermediate of the dissociation of ferrous gluconate and is therefore a reasonable surrogate for predicting the effect of the of the parent material . Neither the ferrous ion or D-glucono-1,5-lactoneare are genetically active (Lima et al, 2011). As such Iron Gluconate is considered to be not genetically active based on read-across. Full read across justification is attatched to this endpoint summary
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)